Obsessive-Compulsive Disorder (OCD) can be a debilitating condition that significantly affects daily life, relationships, and overall well-being.

Suicidal ideation, the persistent thoughts of taking one’s own life, is a terrifying experience for anyone facing severe mental health struggles. For individuals battling with chronic depression, trauma, or other psychological conditions, these thoughts can feel overwhelming and impossible to escape.

Patients suffering from post-traumatic stress disorder (PTSD) or severe trauma-related memories, finding relief is often challenging. Traditional therapies, such as cognitive-behavioral therapy (CBT) and medications work only sometimes.

Transcranial Magnetic Stimulation (TMS) has become very popular for treatment resistant depression, especially for individuals who have not found success with traditional medications or psychotherapy.

Transcranial Magnetic Stimulation (TMS) therapy is the new FDA approved treatment for Obsessive-Compulsive Disorder (OCD), offering hope to those who have not found relief through medications and psychotherapy.

Ketamine, previously used as a anaesthetic agent, has emerged as a groundbreaking treatment for depression, especially for those who haven’t found relief through medications and psychotherapy.

Obsessive-Compulsive Disorder (OCD) has been a difficult disorder to treat and TMS has been the promising new treatment which has shown to be very effective. In this blog post we look at the latest research in this field.

The Rebus theory in the context of Ketamine therapy refers to the idea that psychedelics can temporarily relax or “unlock” the brain’s rigid belief systems and mental models.

Transcranial Magnetic Stimulation (TMS), a non-invasive neuromodulation technique that has gained attention for its potential in treating cocaine use disorder (CUD).